Cosmetic surgery tourism: the hidden risks behind UK women’s blepharoplasty warnings

The NHS rarely performs cosmetic procedures. Yet in recent weeks, British hospitals have treated a growing number of women returning from abroad with open wounds, infected eyelids, and an inability to close their eyes—all complications of a procedure marketed as a quick, affordable fix: blepharoplasty, or eyelid surgery. The trend has prompted warnings from UK medical professionals about the risks of medical tourism, particularly for surgeries that promise dramatic results at a fraction of domestic prices.

The blepharoplasty boom and its aftermath

Blepharoplasty, a surgical procedure to remove excess skin or fat from the eyelids, has surged in popularity over the past decade. In the UK, the operation typically costs between £2,500 and £4,500 when performed privately. Abroad, however, clinics in Turkey, Poland, and other medical tourism hubs offer the same procedure for as little as £800, including flights and accommodation. The savings are undeniable—but so, increasingly, are the risks.

According to the British Association of Aesthetic Plastic Surgeons (BAAPS), the number of UK patients seeking cosmetic procedures abroad has risen by 40% since 2020. Blepharoplasty is now among the top three most requested surgeries for medical tourists, alongside breast augmentation and liposuction. Yet while the allure of low-cost treatment is strong, the aftermath is often far from straightforward.

Three women, speaking to the BBC, described harrowing experiences after undergoing blepharoplasty in Turkey. One reported that her eyelids became so infected she was "scared to sleep," fearing she might lose her sight. Another said her wounds remained open for weeks, requiring multiple corrective surgeries upon her return to the UK. A third described chronic dryness and discomfort, with her eyes unable to fully close—a condition known as lagophthalmos, which can lead to corneal damage if untreated.

Why the UK is sounding the alarm

The complications reported by these women are not isolated incidents. The Royal College of Ophthalmologists (RCOphth) has warned that blepharoplasty carries a higher risk of severe complications than many other cosmetic procedures, particularly when performed in unregulated settings. Unlike in the UK, where cosmetic surgeons must be registered with the General Medical Council (GMC) and clinics are subject to Care Quality Commission (CQC) inspections, overseas providers often operate under far less stringent oversight.

Dr. Mary O’Brien, a consultant ophthalmic surgeon and RCOphth council member, told the BBC that the rise in post-blepharoplasty complications was "deeply concerning." She highlighted three key risks: infection, asymmetry, and nerve damage. "Eyelid surgery is not just about aesthetics—it’s a functional procedure," she said. "If done poorly, it can impair vision, cause chronic pain, and even lead to permanent disfigurement."

The issue is compounded by the lack of recourse for UK patients. While domestic clinics are required to offer aftercare and corrective treatment, overseas providers often disclaim responsibility once the patient leaves the country. Travel insurance rarely covers complications from elective cosmetic procedures, leaving patients to foot the bill for corrective surgery—sometimes costing more than the original procedure.

The broader debate: who regulates medical tourism?

The blepharoplasty warnings come at a time when the UK is grappling with how to regulate medical tourism more broadly. In 2025, the government introduced new guidelines requiring UK-based agencies that facilitate overseas cosmetic procedures to provide clear information about risks and aftercare. However, enforcement remains patchy, and many patients book directly with foreign clinics online, bypassing any regulatory safeguards.

The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) has called for tighter controls, including mandatory cooling-off periods for patients considering cosmetic surgery abroad. "We’re not saying people shouldn’t travel for treatment," said BAPRAS president Mr. Marc Pacifico. "But they need to understand that if something goes wrong, they may have no legal protection—and the NHS may not be able to help."

For now, the warnings appear to be having little impact on demand. Social media platforms remain awash with advertisements for "blepharoplasty holidays," often featuring before-and-after photos that downplay the risks. Meanwhile, UK hospitals continue to see a steady stream of patients requiring corrective surgery after botched procedures abroad.

What happens next?

The blepharoplasty controversy has reignited calls for a public awareness campaign about the risks of medical tourism. The Department of Health and Social Care (DHSC) has indicated it is reviewing the issue, though no concrete policy changes have been announced. In the meantime, UK doctors are urging patients to research clinics thoroughly, seek out GMC-registered surgeons, and consider the long-term costs—not just the upfront savings.

For the women who have already suffered complications, the message is clear: the promise of a quick, cheap fix can come at a far higher price than they ever imagined. As one patient put it: "I thought I was saving money. Now I’m paying for it every time I look in the mirror."